Generics 17

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Neostigmine manufacturers

17 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

17 products found

neostigmine

Injection, pre-filled syringe 0.5 mg / 10 ml, 10 mg / 10 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Available for
Technology transfer
Manufacturer #42
This pharmaceutical company specializes in developing and supplying generic drugs to regulated and emerging markets across the globe. With a focus on transparency, reliability, and integrity, they offer a comprehensive range of services including product development, manufacturing, and supply chain management. They possess an experienced research and development team capable of creating complex formulations that meet diverse regulatory requirements. The company boasts a strong track record in delivering affordable quality generic medicines, serving key regions like the EU, North America, and Asia. Their product portfolio includes solid dosage forms, and they have secured EU and US GMP approvals for their manufacturing facilities. While specific therapy areas are not explicitly mentioned, the company's commitment to innovation and meeting evolving market demands suggests they cater to various therapeutic needs. This company's commitment to quality, affordability, and customer satisfaction has solidified its position as a leading player in the generic pharmaceutical industry.

Manufacturer usually replies in 13 days

neostigmine

Solution for injection 0.5 mg/ml, 1 mg/ml - 10 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, TGA, WHO
Manufacturer #12792
This company focuses on nurturing healthy living through a range of pharmaceutical products aiding in disease treatment and prevention. They offer branded formulations, specialty generics, injectables, vaccines, and biologics across various therapy areas. Key product lines include prescription medications, over-the-counter drugs, and vaccines targeting diseases like Hepatitis B, Covid-19, Diphtheria, Tetanus, Pertussis, and Japanese Encephalitis. Principal dosage forms include injections and oral formulations. The company operates in regions like the EU and North America, adhering to strict GMP certifications for quality assurance. They also hold patents for specific products, highlighting their commitment to innovation.

Manufacturer usually replies in 31 days

neostigmine

Ampoules, injection 0.5 mg/ml, 2.5 mg/ml - 1 ml, 5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #10323
This company is a global manufacturer of essential lifesaving medicaments, specializing in high-tech parenteral and oral formulations. Established in 1984, it has grown from a small family business to a multinational corporation with over 2000 employees across 70 markets. Their expertise spans various therapeutic areas including anaesthesiology, critical care, pain management, gynaecology, ophthalmology, orthopaedics, oncology, and dermatology. They offer a diverse product portfolio of over 500 products, including injectables, infusions, and other dosage forms. The company prides itself on its commitment to quality, innovation, ethics, and transparency. They maintain GMP certifications and hold patents for several products. Their manufacturing sites are strategically located across key regions like the EU and North America.

Manufacturer usually replies in 13 days

Want to see all 17 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible